在中国普通人口中使用HAMPROW评分评估胃风险
Binli Wang1, Weitao Yu2,3, Zheyu Zhang4
1Department of Neurology, Huzhou Nanxun People's Hospital, Zhejiang Provincial People's Hospital Nanxun District, Huzhou, China.
一个新的HAMPROW评分有效地识别了在中国患胃的高风险个体. 这种工具有助于在抗血小板治疗前预防胃肠道出血.
科学领域:
- 胃肠病学 胃肠病学
- 内部医学 内部医学
- 预防医学 预防医学
背景情况:
- 胃潰瘍 (PUs) 存在胃腸出血的風險,尤其是在抗血小板治療期間.
- 及时识别高风险个体对于有效的预防策略至关重要.
- 对于中国普通人口,需要一个验证的风险评估模型.
研究的目的:
- 确定中国人口中胃潰瘍的獨立風險因素.
- 开发和验证胃风险的预测模型.
- 为了促进早期检测和预防胃肠道出血.
主要方法:
- 对902名接受胃镜检查的患者进行前性研究 (2019年4月-2022年5月).
- 来自LASSO的后勤回归分析,以确定风险因素并制定HAMPROW评分.
- 开发的风险评分的时间验证.
主要成果:
- 确定了七个独立的危险因素:男性性别,白细胞计数,红细胞计数,血球蛋白水平,白蛋白水平,辛素I水平和阳性Helicobacter pylori抗体.
- 汉普罗得分显示出强大的预测能力,AUC为0.854 (发展) 和0.833 (验证).
- 该得分有效地预测了中国人口的胃风险.
结论:
- 汉普罗评分是检查中国普通人口胃风险的可靠工具.
- 该模型支持个性化早期检测高风险个体.
- 早期风险评估可以帮助预防与抗血小板治疗相关的胃肠道出血.
更多相关视频
03:47Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
相关概念视频
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
